{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T08:10:41Z","timestamp":1789027841946,"version":"build-2803163510"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"DOI":"10.1007\/s00210-026-05882-w","type":"journal-article","created":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T06:36:34Z","timestamp":1789022194000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Vismodegib-loaded ufasomes inhaler for treatment of non-small cell lung cancer"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0082-4160","authenticated-orcid":false,"given":"Amr Gamal","family":"Fouad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Musaad M.","family":"Althobaiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amany","family":"Belal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeed Saad A.","family":"Alghamdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aali","family":"Alqarni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatma I. Abo","family":"El-Ela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8055-6671","authenticated-orcid":false,"given":"Mary Eskander","family":"Attia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,10]]},"reference":[{"key":"5882_CR1","doi-asserted-by":"publisher","DOI":"10.1039\/d5pm00161g","author":"U Abdi","year":"2026","unstructured":"Abdi U, Zhang M, Al-Jamal WT (2026) Development of vismodegib-loaded PLGA nanoparticles for the treatment of pancreatic cancer: formulation and in vitro assessment in co-culture monolayers and spheroids. RSC Pharm. https:\/\/doi.org\/10.1039\/d5pm00161g","journal-title":"RSC Pharm"},{"issue":"9","key":"5882_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15092242","volume":"15","author":"HA Abou-Taleb","year":"2023","unstructured":"Abou-Taleb HA, Aldosari BN, Zaki RM, Afzal O, Tulbah AS, Shahataa MG, Abo El-Ela FI, Salem HF, Fouad AG (2023) Formulation and therapeutic evaluation of isoxsuprine-loaded nanoparticles against diabetes-associated stroke. Pharmaceutics 15(9):2242. https:\/\/doi.org\/10.3390\/pharmaceutics15092242","journal-title":"Pharmaceutics"},{"key":"5882_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2024.105686","volume":"96","author":"HA Abou-Taleb","year":"2024","unstructured":"Abou-Taleb HA, Zaki RM, Hefny AA, Afzal O, Shahataa MG, El-Ela FIA, Abo El-Ela FI, Salem HF, Fouad AG (2024) In vitro and in vivo evaluation of isoxsuprine loaded invasomes for efficient treatment of diabetes\u2010accelerated atherosclerosis. J Drug Deliv Sci Technol 96:105686","journal-title":"J Drug Deliv Sci Technol"},{"issue":"12","key":"5882_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/ph17121605","volume":"17","author":"HM Aboud","year":"2024","unstructured":"Aboud HM, Ali AA, Mohammed NH, Hassan AH, Roh EJ, El Menshawe SF (2024) Investigating the potential of ufasomes laden with nintedanib as an optimized targeted lung nanoparadigm for accentuated tackling of idiopathic pulmonary fibrosis. Pharmaceuticals (Basel) 17(12):1605","journal-title":"Pharmaceuticals (Basel)"},{"issue":"1","key":"5882_CR5","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1080\/10717544.2022.2103600","volume":"29","author":"S Ahmed","year":"2022","unstructured":"Ahmed S, Amin MM, El-Korany SM, Sayed S (2022) Corneal targeted fenticonazole nitrate-loaded novasomes for the management of ocular candidiasis: preparation, in vitro characterization, ex vivo and in vivo assessments. Drug Deliv 29(1):2428\u20132441","journal-title":"Drug Deliv"},{"issue":"1","key":"5882_CR6","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1080\/10717544.2022.2057619","volume":"29","author":"R Albash","year":"2022","unstructured":"Albash R, Ragaie MH, Hassab MAE, El-Haggar R, Eldehna WM, Al-Rashood ST, Mosallam S (2022) Fenticonazole nitrate loaded trans-novasomes for effective management of tinea corporis: design characterization, in silico study, and exploratory clinical appraisal. Drug Deliv 29(1):1100\u20131111","journal-title":"Drug Deliv"},{"key":"5882_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.molliq.2025.129021","author":"PKS Arya","year":"2025","unstructured":"Arya PKS, Jindal A, Kumar A (2025) Cytotoxicity potential of basil oil embedded 5-fluorouracil-phospholipid complex loaded self-nanoemulsifying system: design expert\u00ae endorsed approach for bioavailability enhancement. J Mol Liq. https:\/\/doi.org\/10.1016\/j.molliq.2025.129021","journal-title":"J Mol Liq"},{"issue":"2","key":"5882_CR8","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s13346-018-0526-4","volume":"9","author":"AA Asmawi","year":"2019","unstructured":"Asmawi AA, Salim N, Ngan CL, Ahmad H, Abdulmalek E, Masarudin MJ, Abdul Rahman MB (2019) Excipient selection and aerodynamic characterization of nebulized lipid-based nanoemulsion loaded with docetaxel for lung cancer treatment. Drug Deliv Transl Res 9(2):543\u2013554","journal-title":"Drug Deliv Transl Res"},{"key":"5882_CR9","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.ijpharm.2019.05.002","volume":"565","author":"MN Calienni","year":"2019","unstructured":"Calienni MN, Febres-Molina C, Llovera RE, Zevallos-Delgado C, Tuttolomondo ME, Paolino D, Fresta M, Barazorda-Ccahuana HL, G\u00f3mez B, Alonso SdV, Montanari J, del Valle Alonso S (2019) Nanoformulation for potential topical delivery of vismodegib in skin cancer treatment. Int J Pharm 565:108\u2013122","journal-title":"Int J Pharm"},{"issue":"20","key":"5882_CR10","doi-asserted-by":"publisher","first-page":"11026","DOI":"10.1039\/C9RA00834A","volume":"9","author":"Y Chen","year":"2019","unstructured":"Chen Y, Yang C, Mao J, Li H, Ding J, Zhou W (2019) Spermine modified polymeric micelles with pH-sensitive drug release for targeted and enhanced antitumor therapy. RSC Adv 9(20):11026\u201311037","journal-title":"RSC Adv"},{"issue":"7","key":"5882_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics16070878","volume":"16","author":"H-H Chen","year":"2024","unstructured":"Chen H-H, Sang C-H, Chou C-W, Lin Y-T, Chang Y-S, Chiu H-C (2024) Solid lipid nanoparticles loaded with dexamethasone palmitate for pulmonary inflammation treatment by nebulization approach. Pharmaceutics 16(7):878","journal-title":"Pharmaceutics"},{"issue":"3","key":"5882_CR12","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3390\/jnt6030019","volume":"6","author":"F Choudhary","year":"2025","unstructured":"Choudhary F, Naikoo UM, Rizwan A, Kaur J, Abdin MZ, Farooqi H (2025) Innovation in lung cancer management from herbal nanomedicine to artificial intelligence. J Nanotheranostics 6(3):19","journal-title":"J Nanotheranostics"},{"issue":"5","key":"5882_CR13","doi-asserted-by":"publisher","first-page":"457","DOI":"10.30802\/AALAS-JAALAS-21-000125","volume":"61","author":"EM David","year":"2022","unstructured":"David EM, Pacharinsak C, Jampachaisri K, Hagan L, Marx JO (2022) Use of ketamine or xylazine to provide balanced anesthesia with isoflurane in C57BL\/6J mice. J Am Assoc Lab Anim Sci 61(5):457\u2013467","journal-title":"J Am Assoc Lab Anim Sci"},{"key":"5882_CR14","doi-asserted-by":"crossref","unstructured":"Davou GI, Chuwang NJ, Essien U,\u00a0 Choji T, Echeonwu B, Lugos M (2019) Cytotoxicity analysis of etoposide and cisplatin on cell lines from human lung cancer and normal human lung. Int J Med Med Sci, 7(2):40\u201347","DOI":"10.30918\/IRJMMS.72.19.022"},{"issue":"7","key":"5882_CR15","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1111\/1759-7714.13449","volume":"11","author":"C de Jong","year":"2020","unstructured":"de Jong C, Deneer VH, Kelder JC, Ruven H, Egberts TC, Herder GJ (2020) Association between serum biomarkers CEA and LDH and response in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy. Thoracic Cancer 11(7):1790\u20131800","journal-title":"Thoracic Cancer"},{"key":"5882_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2020.120091","volume":"592","author":"NS El-Salamouni","year":"2021","unstructured":"El-Salamouni NS, Gowayed MA, Seiffein NL, Abdel-Moneim RA, Kamel MA, Labib GS (2021) Valsartan solid lipid nanoparticles integrated hydrogel: a challenging repurposed use in the treatment of diabetic foot ulcer, in-vitro\/in-vivo experimental study. Int J Pharm 592:120091","journal-title":"Int J Pharm"},{"issue":"1","key":"5882_CR17","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.1080\/10717544.2022.2092236","volume":"29","author":"MH Elkomy","year":"2022","unstructured":"Elkomy MH, El Menshawe SF, Kharshoum RM, Abdeltwab AM, Hussein RR, Hamad DS, Hussein RRS, Alsalahat I, Aboud HM (2022) Innovative pulmonary targeting of terbutaline sulfate-laded novasomes for non-invasive tackling of asthma: statistical optimization and comparative in vitro\/in vivo evaluation. Drug Deliv 29(1):2058\u20132071","journal-title":"Drug Deliv"},{"issue":"1","key":"5882_CR18","doi-asserted-by":"publisher","first-page":"21","DOI":"10.21608\/sisj.2025.442481","volume":"2","author":"RE Elnady","year":"2025","unstructured":"Elnady RE (2025) A comprehensive review on novasomes as lipid-based drug carriers. Sinai International Scientific Journal 2(1):21\u201335","journal-title":"Sinai International Scientific Journal"},{"issue":"9","key":"5882_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27092936","volume":"27","author":"I Fatima","year":"2022","unstructured":"Fatima I, Rasul A, Shah S, Saadullah M, Islam N, Khames A, Salawi A, Ahmed MM, Almoshari Y, Abourehab MAS, Mehmood Khan S, Chauhdary Z, Alshamrani M, Namazi NI, Naguib DM, Abbas G (2022) Novasomes as nano-vesicular carriers to enhance topical delivery of fluconazole: a new approach to treat fungal infections. Molecules 27(9):2936","journal-title":"Molecules"},{"issue":"2","key":"5882_CR20","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1007\/s13346-023-01412-w","volume":"14","author":"AG Fouad","year":"2024","unstructured":"Fouad AG, Ali MR, Naguib DM, Farouk HO, Zanaty MI, El-Ela FIA (2024) Design, optimization, and in vivo evaluation of invasome-mediated candesartan for the control of diabetes-associated atherosclerosis. Drug Deliv Transl Res 14(2):474\u2013490","journal-title":"Drug Deliv Transl Res"},{"key":"5882_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.onano.2023.100186","volume":"14","author":"EA Fr\u00edas","year":"2023","unstructured":"Fr\u00edas EA, Vega DM, Calienni MN, Lillo C, Vazquez DS, Alonso S, Montanari J (2023) Enhanced skin delivery of vismodegib-loaded rigid liposomes combined with ethosomes. OpenNano 14:100186","journal-title":"OpenNano"},{"issue":"10","key":"5882_CR22","doi-asserted-by":"publisher","first-page":"3103","DOI":"10.1016\/j.xphs.2017.04.060","volume":"106","author":"MM Gabr","year":"2017","unstructured":"Gabr MM, Mortada SM, Sallam MA (2017) Hexagonal liquid crystalline nanodispersions proven superiority for enhanced oral delivery of rosuvastatin: in vitro characterization and in vivo pharmacokinetic study. J Pharm Sci 106(10):3103\u20133112","journal-title":"J Pharm Sci"},{"key":"5882_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2020.101556","volume":"56","author":"FA Gamal","year":"2020","unstructured":"Gamal FA, Kharshoum RM, Sayed OM, El-Ela FIA, Salem HF (2020) Control of basal cell carcinoma via positively charged ethosomes of Vismodegib: in vitro and in vivo studies. J Drug Deliv Sci Technol 56:101556","journal-title":"J Drug Deliv Sci Technol"},{"key":"5882_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpx.2025.100482","author":"SM Ghazwani","year":"2025","unstructured":"Ghazwani SM, Alhazmi S, Ghazwani SM, Shubaily HM, Wafi AM, Alenazi N, Qadri M, Alshammari AN, Mawkili W, Khired Z, Salama SA, Moshi JM (2025) Improving the bioavailability of nintedanib by formulating inhalable ufasomes as a targeted therapy for non-small cell lung cancer. International Journal of Pharmaceutics: X. https:\/\/doi.org\/10.1016\/j.ijpx.2025.100482","journal-title":"International Journal of Pharmaceutics: X"},{"issue":"9","key":"5882_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15092259","volume":"15","author":"S Gulshan","year":"2023","unstructured":"Gulshan S, Shah S, Shah PA, Irfan M, Saadullah M, Abbas G, Hanif M, Rasul A, Ahmad N, Basheer E, Habib MO, Alotaibi HF, Obaidullah AJ, Alsabhan JF, Alwassil Ol, Mahmood A (2023) Development and pharmacokinetic evaluation of novasomes for the trans-nasal delivery of fluvoxamine using arachidonic acid-carboxymethyl chitosan conjugate. Pharmaceutics 15(9):2259","journal-title":"Pharmaceutics"},{"issue":"5","key":"5882_CR26","first-page":"4550","volume":"17","author":"G He","year":"2019","unstructured":"He G, Jiang Z, Xue S, Sun X, Wang W (2019) Expression of LDH and CEA in serum in the process of targeted therapy of lung adenocarcinoma and the association between them and prognosis. Oncol Lett 17(5):4550\u20134556","journal-title":"Oncol Lett"},{"issue":"1","key":"5882_CR27","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/s41598-023-50703-2","volume":"14","author":"Q He","year":"2024","unstructured":"He Q, Sun C, Pan Y (2024) Whole-exome sequencing reveals Lewis lung carcinoma is a hypermutated Kras\/Nras\u2013mutant cancer with extensive regional mutation clusters in its genome. Sci Rep 14(1):100","journal-title":"Sci Rep"},{"key":"5882_CR28","doi-asserted-by":"publisher","DOI":"10.1177\/15347354221144312","volume":"21","author":"J Huang","year":"2022","unstructured":"Huang J, Li J-X, Ma L-R, Xu D-H, Wang P, Li L-Q, Yu L-L, Li Y, Li R-Z, Zheng Y-H, Tang L, Yan P-Y, Zhang H (2022) Traditional herbal medicine: a potential therapeutic approach for adjuvant treatment of non-small cell lung cancer in the future. Integr Cancer Ther 21:15347354221144312","journal-title":"Integr Cancer Ther"},{"key":"5882_CR29","doi-asserted-by":"crossref","unstructured":"illastria Rosalina A, Sagita E, Iskandarsyah I (2023) Novasome: combining ufasome and niosome for excellent vesicular drug delivery system. Sciences of Pharmacy 2(1):26\u201336","DOI":"10.58920\/sciphar02010035"},{"issue":"2","key":"5882_CR30","doi-asserted-by":"publisher","first-page":"920","DOI":"10.5958\/0974-360X.2019.00157.4","volume":"12","author":"SM Jayeshkumar","year":"2019","unstructured":"Jayeshkumar SM, Yashvi P, Bhimani B, Patel G, Patel J, Patel U (2019) Nebulization therapy for lung cancer. Res J Pharm Technol 12(2):920\u2013934","journal-title":"Res J Pharm Technol"},{"issue":"1","key":"5882_CR31","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/s41392-023-01559-5","volume":"8","author":"J Jing","year":"2023","unstructured":"Jing J, Wu Z, Wang J, Luo G, Lin H, Fan Y, Zhou C (2023) Hedgehog signaling in tissue homeostasis, cancers and targeted therapies. Signal Transduct Target Ther 8(1):315","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"5882_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0263119","volume":"17","author":"MAS Karal","year":"2022","unstructured":"Karal MAS, Mokta NA, Levadny V, Belaya M, Ahmed M, Ahamed MK, Ahammed S (2022) Effects of cholesterol on the size distribution and bending modulus of lipid vesicles. PLoS ONE 17(1):e0263119","journal-title":"PLoS ONE"},{"issue":"2","key":"5882_CR33","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1080\/08982104.2019.1610435","volume":"30","author":"RA Khallaf","year":"2020","unstructured":"Khallaf RA, Aboud HM, Sayed OM (2020) Surface modified niosomes of olanzapine for brain targeting via nasal route; preparation, optimization, and in vivo evaluation. J Liposome Res 30(2):163\u2013173","journal-title":"J Liposome Res"},{"issue":"1","key":"5882_CR34","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4274\/tjps.galenos.2018.34392","volume":"17","author":"GY Kirimlio\u011flu","year":"2020","unstructured":"Kirimlio\u011flu GY, \u00d6zt\u00fcrk AA (2020) Levocetirizine dihydrochloride-loaded chitosan nanoparticles: formulation and in vitro evaluation. Turkish Journal of Pharmaceutical Sciences 17(1):27","journal-title":"Turkish Journal of Pharmaceutical Sciences"},{"key":"5882_CR35","doi-asserted-by":"crossref","unstructured":"Krishna SR, Ramu A, Vidyadhara S, Prameela Rani A (2021) Bioavailability enhancement by floating microballoons of dipyridamole and clopidogrel: in vivo pharmacokinetic study. Intern J Appl Pharmac 13(6):216e220","DOI":"10.22159\/ijap.2021v13i6.42316"},{"key":"5882_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.envint.2024.108928","volume":"190","author":"W Ma","year":"2024","unstructured":"Ma W, Xu L, Wang Y, Chen S, Li D, Huo X, Li R, Zhu X, Chen N, Luo J, Li C, Zhao K, Zheng Y, Han W, Yu D, Jin Y (2024) PiR-27222 mediates PM2. 5-induced lung cancer by resisting cell PANoptosis through the WTAP\/m6A axis. Environ Int 190:108928","journal-title":"Environ Int"},{"issue":"11","key":"5882_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.xphs.2025.103998","volume":"114","author":"TM Mahmoud","year":"2025","unstructured":"Mahmoud TM, Fouad AG, Belal A, Ismail A, Baali FH, Alharthi MS, Hassan AHE, Roh EJ, Tulbah AS, El-Ela FIA (2025) Evaluating the bioavailability and therapeutic efficacy of nintedanib-loaded novasomes as a therapy for non-small cell lung cancer. J Pharm Sci 114(11):103998","journal-title":"J Pharm Sci"},{"issue":"1","key":"5882_CR38","doi-asserted-by":"publisher","first-page":"36","DOI":"10.5530\/jyp.20251440","volume":"17","author":"MA Mustafa","year":"2025","unstructured":"Mustafa MA, Rasheed N, Ayesha M, ul Ain Q, Mughal M, Fahad M, Ain Qu, Shakir H, Ijaz A, Tahir MA, Ali M, Kainat A, Muhammad M (2025) Novasomes: a versatile drug delivery system for enhanced therapeutic efficacy. J Young Pharm 17(1):36","journal-title":"J Young Pharm"},{"issue":"1","key":"5882_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-025-15015-w","volume":"25","author":"F Naureen","year":"2025","unstructured":"Naureen F, Shah Y, Rehman MU, Fazli Nasir FN, Pirzada AS, Al-Otaibi JS, Daglia M, Khan H (2025) Innovative inhalable dry powder: nanoparticles loaded with Crizotinib for targeted lung cancer therapy. BMC Cancer 25(1):1526","journal-title":"BMC Cancer"},{"issue":"16","key":"5882_CR40","doi-asserted-by":"publisher","first-page":"8661","DOI":"10.3390\/ijms22168661","volume":"22","author":"R Nooreldeen","year":"2021","unstructured":"Nooreldeen R, Bach H (2021) Current and future development in lung cancer diagnosis. Int J Mol Sci 22(16):8661","journal-title":"Int J Mol Sci"},{"issue":"3","key":"5882_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics12030206","volume":"12","author":"V Parvathaneni","year":"2020","unstructured":"Parvathaneni V, Kulkarni NS, Shukla SK, Farrales PT, Kunda NK, Muth A, Gupta V (2020) Systematic development and optimization of inhalable pirfenidone liposomes for non-small cell lung cancer treatment. Pharmaceutics 12(3):206","journal-title":"Pharmaceutics"},{"issue":"1","key":"5882_CR42","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1080\/10717544.2022.2086938","volume":"29","author":"C Pi","year":"2022","unstructured":"Pi C, Zhao W, Zeng M, Yuan J, Shen H, Li K, Su Z, Liu Z, Wen J, Lee RJ, Wei Y, Zhao L, Song X (2022) Anti-lung cancer effect of paclitaxel solid lipid nanoparticles delivery system with curcumin as co-loading partner in vitro and in vivo. Drug Deliv 29(1):1878\u20131891","journal-title":"Drug Deliv"},{"key":"5882_CR43","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s11947-020-02419-8","volume":"13","author":"CMB Pinilla","year":"2020","unstructured":"Pinilla CMB, Reque PM, Brandelli A (2020) Effect of oleic acid, cholesterol, and octadecylamine on membrane stability of freeze-dried liposomes encapsulating natural antimicrobials. Food Bioprocess Technol 13:599\u2013610","journal-title":"Food Bioprocess Technol"},{"issue":"421","key":"5882_CR44","first-page":"2","volume":"10","author":"V Pulusu","year":"2019","unstructured":"Pulusu V, Kommarajula P (2019) Development and validation of a new chromatographic method for the estimation of Vismodegib by RP-HPLC. J Chromatogr Sep Tech 10(421):2","journal-title":"J Chromatogr Sep Tech"},{"issue":"10","key":"5882_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13101677","volume":"13","author":"HA Saafan","year":"2021","unstructured":"Saafan HA, Ibrahim KM, Thabet Y, Elbeltagy SM, Eissa RA, Ghaleb AH, Ibrahim F, Elsabahy M, Eissa NG (2021) Intratracheal administration of chloroquine-loaded niosomes minimize systemic drug exposure. Pharmaceutics 13(10):1677","journal-title":"Pharmaceutics"},{"issue":"2","key":"5882_CR46","doi-asserted-by":"publisher","DOI":"10.3390\/ph15020126","volume":"15","author":"HF Salem","year":"2022","unstructured":"Salem HF, Gamal A, Saeed H, Kamal M, Tulbah AS (2022) Enhancing the bioavailability and efficacy of vismodegib for the control of skin cancer: in vitro and in vivo studies. Pharmaceuticals (Basel) 15(2):126","journal-title":"Pharmaceuticals (Basel)"},{"issue":"13","key":"5882_CR47","doi-asserted-by":"publisher","first-page":"935","DOI":"10.2217\/nnm-2022-0045","volume":"17","author":"SK Shukla","year":"2022","unstructured":"Shukla SK, Nguyen V, Goyal M, Gupta V (2022) Cationically modified inhalable nintedanib niosomes: enhancing therapeutic activity against non-small-cell lung cancer. Nanomedicine (Lond) 17(13):935\u2013958","journal-title":"Nanomedicine (Lond)"},{"key":"5882_CR48","unstructured":"Singh AP, Puri D, Chauhan I, Jindal A, Kumar J, Kumar N, . . . Dhiman P (2025) Modulation of anti-inflammatory activity via diclofenac sodium-based nanostructured-lipid carriers: physical characterization and in vivo assessment. ASSAY\u00a0 Drug Dev Technol 23(8):418\u2013432"},{"issue":"1","key":"5882_CR49","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1002\/2211-5463.13486","volume":"13","author":"R Tanaka","year":"2023","unstructured":"Tanaka R, Yoshinouchi S, Karouji K, Tanaka Y, Tominari T, Hirata M, Matsumoto C, Itoh Y, Miyaura C, Inada M (2023) A mouse model of lung cancer induced via intranasal injection for anticancer drug screening and evaluation of pathology. FEBS Open Bio 13(1):51\u201359","journal-title":"FEBS Open Bio"},{"key":"5882_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1208\/s12249-021-02147-y","volume":"22","author":"MA Tawfik","year":"2021","unstructured":"Tawfik MA, Mohamed MI, Tadros MI, El-Helaly SN (2021) Low-frequency sonophoresis as an active approach to potentiate the transdermal delivery of agomelatine-loaded novasomes: design, optimization, and pharmacokinetic profiling in rabbits. AAPS PharmSciTech 22:1\u201315","journal-title":"AAPS PharmSciTech"},{"issue":"3","key":"5882_CR51","first-page":"1009","volume":"46","author":"S \u00dcnal","year":"2022","unstructured":"\u00dcnal S, Do\u011fan O, Akta\u015f Y (2022) Paclitaxel-loaded polycaprolactone nanoparticles for lung tumors; formulation, comprehensive in vitro characterization and release kinetic studies. J Fac Pharm Ankara Univ 46(3):1009\u20131029","journal-title":"J Fac Pharm Ankara Univ"},{"issue":"1","key":"5882_CR52","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s12951-024-02446-z","volume":"22","author":"H Wang","year":"2024","unstructured":"Wang H, Tang C, Xiang Y, Zou C, Hu J, Yang G, Zhou W (2024a) Tea polyphenol-derived nanomedicine for targeted photothermal thrombolysis and inflammation suppression. J Nanobiotechnol 22(1):146","journal-title":"J Nanobiotechnol"},{"issue":"2","key":"5882_CR53","doi-asserted-by":"publisher","DOI":"10.4110\/in.2024.24.e3","volume":"24","author":"L Wang","year":"2024","unstructured":"Wang L, Yu Q, Xiao J, Chen Q, Fang M, Zhao H (2024b) Cigarette smoke extract-treated mouse airway epithelial cells-derived exosomal LncRNA MEG3 promotes M1 macrophage polarization and pyroptosis in chronic obstructive pulmonary disease by upregulating TREM-1 via m6A methylation. Immune Netw 24(2):e3","journal-title":"Immune Netw"},{"key":"5882_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2023.105233","volume":"91","author":"X Wang","year":"2024","unstructured":"Wang X, Gadhave D, Chauhan G, Gupta V (2024c) Development and characterization of inhaled nintedanib-loaded PLGA nanoparticles using scalable high-pressure homogenization technique. J Drug Deliv Sci Technol 91:105233","journal-title":"J Drug Deliv Sci Technol"},{"issue":"2","key":"5882_CR55","doi-asserted-by":"publisher","DOI":"10.1111\/cbdd.70258","volume":"107","author":"M Wu","year":"2026","unstructured":"Wu M, Quan C, Yao L, Yang Y, Liu J, Zhu Q (2026) The therapeutic effect and mechanism of vismodegib on COPD: focusing on NETs and macrophage polarization. Chem Biol Drug des 107(2):e70258","journal-title":"Chem Biol Drug des"},{"issue":"5","key":"5882_CR56","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.7150\/ijbs.92988","volume":"20","author":"W-X Xu","year":"2024","unstructured":"Xu W-X, Qu Q, Zhuang H-H, Teng X-Q, Wei Y-W, Luo J, Dai Y-H, Qu J (2024) The burgeoning significance of liquid-liquid phase separation in the pathogenesis and therapeutics of cancers. Int J Biol Sci 20(5):1652","journal-title":"Int J Biol Sci"},{"key":"5882_CR57","unstructured":"Xu BL, Wang XM, Chen GY, Yuan P, Han L, Qin P, . . . Fu XM (2022) In vivo growth of subclones derived from Lewis lung carcinoma is determined by the tumor microenvironment. Am J Cancer Res 12(11):5255"},{"issue":"4","key":"5882_CR58","doi-asserted-by":"publisher","first-page":"3499","DOI":"10.1007\/s12013-024-01438-y","volume":"82","author":"W-C Yeh","year":"2024","unstructured":"Yeh W-C, Tu Y-C, Hsu P-L, Lee C-W, Yu H-H, Su B-C (2024) Combination of vismodegib and paclitaxel enhances cytotoxicity via bak-mediated mitochondrial damage in EGFR-mutant non-small cell lung cancer cells. Cell Biochem Biophys 82(4):3499\u20133506","journal-title":"Cell Biochem Biophys"},{"issue":"3","key":"5882_CR59","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1208\/s12248-010-9185-1","volume":"12","author":"Y Zhang","year":"2010","unstructured":"Zhang Y, Huo M, Zhou J, Zou A, Li W, Yao C, Xie S (2010) DDSolver: an add-in program for modeling and comparison of drug dissolution profiles. AAPS J 12(3):263\u2013271","journal-title":"AAPS J"},{"issue":"3","key":"5882_CR60","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.apsb.2018.03.004","volume":"8","author":"T Zhang","year":"2018","unstructured":"Zhang T, Chen Y, Ge Y, Hu Y, Li M, Jin Y (2018) Inhalation treatment of primary lung cancer using liposomal curcumin dry powder inhalers. Acta Pharm Sin B 8(3):440\u2013448","journal-title":"Acta Pharm Sin B"},{"key":"5882_CR61","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1556209","volume":"16","author":"R Zhu","year":"2025","unstructured":"Zhu R, Huang J, Qian F (2025) The role of tumor-associated macrophages in lung cancer. Front Immunol 16:1556209","journal-title":"Front Immunol"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05882-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05882-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05882-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T08:05:33Z","timestamp":1789027533000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-026-05882-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,10]]},"references-count":61,"alternative-id":["5882"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-05882-w","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,10]]},"assertion":[{"value":"29 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The ethics committee at Beni-Suef University gave their stamp of approval to the study (022\u2013283).","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Human subjects were not involved in any of the studies conducted by the authors.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}